Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.27
Price to sales ratio
13.5

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2484
ANRO
Alto Neuroscience, Inc. Common Stock
28.03 USD+5.93%+5.34%+30.25%+930.51%983.68 M USD
2486
VOR
Vor Biopharma Inc. - Common Stock
18.03 USD-5.80%-10.74%+22.24%+37.63%976.97 M USD
2497
PHAR
Pharming Group N.V. - ADS, each representing 10
13.75 USD+0.22%-4.71%+4.56%+31.96%964.81 M USD
2498
LXRX
Lexicon Pharmaceuticals, Inc. - Common Stock
2.17 USD-2.25%-6.47%+11.28%+82.35%963.91 M USD

Frequently asked questions about Kura Oncology, Inc. - Common Stock

What is the Kura Oncology, Inc. - Common Stock stock price today?

The current price of Kura Oncology, Inc. - Common Stock (KURA) is 10.91. Over the past 24 hours, the stock has changed by -4.72%. Follow the KURA chart for real-time price dynamics.

What is the stock ticker of Kura Oncology, Inc. - Common Stock?

Kura Oncology, Inc. - Common Stock trades under the ticker KURA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Kura Oncology, Inc. - Common Stock stock going up?

KURA has changed by -2.76% over the last week, +18.85% over the last month, and +70.74% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Kura Oncology, Inc. - Common Stock net income for the last quarter?

Kura Oncology, Inc. - Common Stock reported net income of -73.33 M for the last quarter. The previous quarter showed -81 M, which means net income changed by +9.46%.

How many employees does Kura Oncology, Inc. - Common Stock have?

As of the latest available data, Kura Oncology, Inc. - Common Stock has 260 employees. Workforce size can provide additional context about the company's scale and operations.

What is Kura Oncology, Inc. - Common Stock EBITDA?

Kura Oncology, Inc. - Common Stock EBITDA is -79.25 M, and its EBITDA margin is -433.91%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Kura Oncology, Inc. - Common Stock stock?

You can buy Kura Oncology, Inc. - Common Stock (KURA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Kura Oncology, Inc. - Common Stock stock?

Investing in Kura Oncology, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KURA chart and related analysis on metatrader.com as part of your research.

News